150 related articles for article (PubMed ID: 12569069)
1. Characterization of human 5-HT4(d) receptor desensitization in CHO cells.
Mialet J; Fischmeister R; Lezoualc'h F
Br J Pharmacol; 2003 Feb; 138(3):445-52. PubMed ID: 12569069
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of the human 5-HT(4(d)) receptor splice variant stably expressed in Chinese hamster ovary cells.
Mialet J; Berque-Bestel I; Sicsic S; Langlois M; Fischmeister R; Lezoualc'h F
Br J Pharmacol; 2000 Oct; 131(4):827-35. PubMed ID: 11030734
[TBL] [Abstract][Full Text] [Related]
3. Characterization of homologous 5-hydroxytryptamine4 receptor desensitization in colliculi neurons.
Ansanay H; Sebben M; Bockaert J; Dumuis A
Mol Pharmacol; 1992 Nov; 42(5):808-16. PubMed ID: 1331763
[TBL] [Abstract][Full Text] [Related]
4. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
Krobert KA; Andressen KW; Levy FO
Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
[TBL] [Abstract][Full Text] [Related]
5. Altered regulation of the D(1) dopamine receptor in mutant Chinese hamster ovary cells deficient in cyclic AMP-dependent protein kinase activity.
Ventura AL; Sibley DR
J Pharmacol Exp Ther; 2000 May; 293(2):426-34. PubMed ID: 10773012
[TBL] [Abstract][Full Text] [Related]
6. Regulation of D(1) dopamine receptors with mutations of protein kinase phosphorylation sites: attenuation of the rate of agonist-induced desensitization.
Jiang D; Sibley DR
Mol Pharmacol; 1999 Oct; 56(4):675-83. PubMed ID: 10496949
[TBL] [Abstract][Full Text] [Related]
7. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
[TBL] [Abstract][Full Text] [Related]
8. Cloning, expression, and pharmacology of four human 5-hydroxytryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus.
Blondel O; Gastineau M; Dahmoune Y; Langlois M; Fischmeister R
J Neurochem; 1998 Jun; 70(6):2252-61. PubMed ID: 9603189
[TBL] [Abstract][Full Text] [Related]
9. The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein.
Robert SJ; Zugaza JL; Fischmeister R; Gardier AM; Lezoualc'h F
J Biol Chem; 2001 Nov; 276(48):44881-8. PubMed ID: 11584021
[TBL] [Abstract][Full Text] [Related]
10. Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling.
Mialet J; Dahmoune Y; Lezoualc'h F; Berque-Bestel I; Eftekhari P; Hoebeke J; Sicsic S; Langlois M; Fischmeister R
Br J Pharmacol; 2000 Jun; 130(3):527-38. PubMed ID: 10821780
[TBL] [Abstract][Full Text] [Related]
11. Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines.
Mialet J; Berque-Bestel I; Eftekhari P; Gastineau M; Giner M; Dahmoune Y; Donzeau-Gouge P; Hoebeke J; Langlois M; Sicsic S; Fischmeister R; Lezoualc'h F
Br J Pharmacol; 2000 Feb; 129(4):771-81. PubMed ID: 10683202
[TBL] [Abstract][Full Text] [Related]
12. Distinct functional effects of human 5-HT4 receptor isoforms on beta-amyloid secretion.
Robert SJ; Lezoualc'h F
Neurodegener Dis; 2008; 5(3-4):163-5. PubMed ID: 18322379
[TBL] [Abstract][Full Text] [Related]
13. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
[TBL] [Abstract][Full Text] [Related]
14. Stable expression of adenylyl cyclase 2 leads to the functional rescue of human 5-HT6 receptor in a CHODUKX cell line.
Nawoschik SP; Olsen M; Smith DL; Khawaja X
J Pharmacol Toxicol Methods; 2007; 55(3):323-31. PubMed ID: 17188522
[TBL] [Abstract][Full Text] [Related]
15. Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies.
Tran TM; Friedman J; Qunaibi E; Baameur F; Moore RH; Clark RB
Mol Pharmacol; 2004 Jan; 65(1):196-206. PubMed ID: 14722251
[TBL] [Abstract][Full Text] [Related]
16. The serotonin 5-HT4 receptor and the amyloid precursor protein processing.
Lezoualc'h F; Robert SJ
Exp Gerontol; 2003; 38(1-2):159-66. PubMed ID: 12543273
[TBL] [Abstract][Full Text] [Related]
17. WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system.
Khawaja XZ; Smith DL; Nawoschik SP; Zhang J; Dunlop J; Dilks DW; Olsen M; Schechter LE
J Neurochem; 2006 Jul; 98(1):134-45. PubMed ID: 16805803
[TBL] [Abstract][Full Text] [Related]
18. Presence of a 5-HT7 receptor positively coupled to adenylate cyclase activation in human granulosa-lutein cells.
Graveleau C; Paust HJ; Schmidt-Grimminger D; Mukhopadhyay AK
J Clin Endocrinol Metab; 2000 Mar; 85(3):1277-86. PubMed ID: 10720076
[TBL] [Abstract][Full Text] [Related]
19. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes.
Newman-Tancredi A; Cussac D; Quentric Y; Touzard M; Verrièle L; Carpentier N; Millan MJ
J Pharmacol Exp Ther; 2002 Nov; 303(2):815-22. PubMed ID: 12388668
[TBL] [Abstract][Full Text] [Related]
20. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
Cussac D; Newman-Tancredi A; Quentric Y; Carpentier N; Poissonnet G; Parmentier JG; Goldstein S; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):242-52. PubMed ID: 11882920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
